Focus Partners Wealth Acquires 3,464 Shares of Astera Labs, Inc. $ALAB

Key Points

• Focus Partners Wealth has increased its holdings in Astera Labs, Inc. by 0.8%, owning a total of 432,806 shares valued at approximately $25.8 million at the end of the recent quarter.
• Several institutional investors, including Sound Income Strategies LLC and Hazlett Burt & Watson Inc., have significantly increased their stakes in Astera Labs, with some raising their holdings by as much as 1,670%.
• Astera Labs recently reported earnings that surpassed analyst expectations, with a quarterly revenue of $191.93 million—up 149.5% from the previous year—while setting a guidance of 0.380-0.390 EPS for Q3 2025.

Focus Partners Wealth increased its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 0.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 432,806 shares of the company's stock after purchasing an additional 3,464 shares during the period. Focus Partners Wealth owned approximately 0.26% of Astera Labs worth $25,826,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Sound Income Strategies LLC lifted its holdings in shares of Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after purchasing an additional 204 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Astera Labs by 55.7% during the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after purchasing an additional 284 shares in the last quarter. Harbour Investments Inc. lifted its holdings in shares of Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after purchasing an additional 619 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Astera Labs in the 1st quarter valued at approximately $48,000. Finally, Hazlett Burt & Watson Inc. raised its position in Astera Labs by 1,670.0% in the 1st quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock valued at $53,000 after buying an additional 835 shares during the last quarter. Institutional investors own 60.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ALAB. Northland Capmk lowered Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. Evercore ISI lifted their target price on Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a research report on Wednesday, August 6th. Susquehanna lifted their target price on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research report on Thursday, August 7th. Northland Securities lowered Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 target price on the stock. in a research report on Tuesday, July 22nd. Finally, CICC Research began coverage on Astera Labs in a research report on Friday, August 29th. They issued an "outperform" rating and a $190.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $142.00.

Insiders Place Their Bets

In related news, CFO Michael Truett Tate sold 100,000 shares of the business's stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total transaction of $17,138,000.00. Following the transaction, the chief financial officer directly owned 518,996 shares of the company's stock, valued at approximately $88,945,534.48. The trade was a 16.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the sale, the director owned 385,863 shares of the company's stock, valued at $66,858,482.01. This trade represents a 32.17% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,832,489 shares of company stock valued at $264,172,396 over the last 90 days. 12.50% of the stock is owned by insiders.

Astera Labs Trading Up 1.1%

ALAB stock opened at $232.90 on Friday. The firm has a market capitalization of $38.71 billion, a PE ratio of 415.89, a PEG ratio of 5.84 and a beta of 1.48. Astera Labs, Inc. has a 1-year low of $40.78 and a 1-year high of $237.82. The business's 50 day simple moving average is $152.34 and its 200 day simple moving average is $102.63.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm's revenue was up 149.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, sell-side analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.